Published in J Pharm Sci on July 01, 2009
Combining immunotherapy with oncogene-targeted therapy: a new road for melanoma treatment. Front Immunol (2015) 1.04
A phase I/II study of chemotherapy followed by donor lymphocyte infusion plus interleukin-2 for relapsed acute leukemia after allogeneic hematopoietic cell transplantation. Biol Blood Marrow Transplant (2011) 0.86
Challenges and developing solutions for increasing the benefits of IL-2 treatment in tumor therapy. Expert Rev Clin Immunol (2014) 0.84
Palmitate-derivatized human IL-2: a potential anticancer immunotherapeutic of low systemic toxicity. Cancer Immunol Immunother (2012) 0.83
Particle-mediated delivery of cytokines for immunotherapy. Immunotherapy (2012) 0.82
In vitro assessment of choline dihydrogen phosphate (CDHP) as a vehicle for recombinant human interleukin-2 (rhIL-2). Cell Mol Bioeng (2012) 0.79
Functional Modulation of Regulatory T Cells by IL-2. PLoS One (2015) 0.75
Oligodeoxynucleotides expressing polyguanosine motifs promote antitumor activity through the upregulation of IL-2. J Immunol (2013) 0.75
The effect of interleukin-2 on canine peripheral nerve sheath tumours after marginal surgical excision: a double-blind randomized study. BMC Vet Res (2013) 0.75
Immunomodulatory Monoclonal Antibodies in Combined Immunotherapy Trials for Cutaneous Melanoma. Front Immunol (2017) 0.75
Sustained interferon-gamma delivery from a photocrosslinked biodegradable elastomer. J Control Release (2005) 0.87
Synthesis and characterization of a photo-cross-linked biodegradable elastomer. Biomacromolecules (2004) 0.81
Osmotic-driven release of papaverine hydrochloride from novel poly(decane-co-tricarballylate) elastomeric matrices. Ther Deliv (2010) 0.75
Synthesis, characterization and cytocompatibility of a poly(diol-tricarballylate) visible light photo-cross-linked biodegradable elastomer. J Biomater Sci Polym Ed (2010) 0.75